Drug level monitoring in children
Mackenzie, S.
Nursing Times 77(17): 736-737
1981
ISSN/ISBN: 0954-7762 PMID: 6909761 Document Number: 172018
Document emailed within 1 workday
Related Documents
Klein, C.; Suchet, I.; Scher, L.G.; Rheeders, M.; Miller, R. 1987: Therapeutic drug level monitoring in the management of epilepsy South African Medical Journal 71(2): 83-85Winkler, M.; Wonigeit, K.; Undre, N.; Ringe, B.; Oldhafer, K.; Christians, U.; Pichlmayr, R. 1995: Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring Transplantation Proceedings 27(1): 822-825
Giangrande, A.; Tortorano, A.M.; Limido, A.; Viviani, M.A. 1983: Management of candida peritonitis in a CAPD patient by flucytosine therapy: importance of drug level monitoring in body fluids Bollettino dell'Istituto Sieroterapico Milanese 62(5): 478-481
Dugas, M.; Zarifian, E.; Le Heuzey, M.F.; Regnier, N.; Durand, G.; Bianchetti, G.; Morselli, P.L. 1982: Plasma level monitoring of psychotropic drugs in children. I-Haloperidol La Nouvelle Presse Medicale 11(29): 2201-2204
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Al'bitskii, V.I.; Ustinova, N.V.; Farrakhov, A.Z.; Shavaliev, R.F.; Kulikov O V; Plaksina, L.V. 2014: The regional model of three-level system of of medical social monitoring of children and adolescents: the pilot project in the Republic of Tatarstan Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 6: 15-17
Peytchev, L.; Chakova, L. 1998: Comparative drug monitoring of carbamazepin suspension (TroyaPharm) and Tegretol syrup (Ciba Geigy) in epileptic children Folia Medica 40(4): 29-33
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Tantikul, C.; Dhana, N.; Jongjarearnprasert, K.; Visitsunthorn, N.; Vichyanond, P.; Jirapongsananuruk, O. 2008: The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children Asian Pacific Journal of Allergy and Immunology 26(2-3): 77-82
Ciorciaro, C.; Hartmann, K.; Stoller, R.; Kuhn, M. 1996: Liver injury caused by coumarin anticoagulants: experience of the IKS (Intercanton Monitoring Station) and the SANZ (Swiss Center for Drug Monitoring) Schweizerische Medizinische Wochenschrift 126(49): 2109-2113
Laptev, D.N.; Kruzhkova, M.N.; Riabykina, G.V.; Poliakov, S.D.; Korneeva, I.T. 2012: Effect of short term graded physical exercise on the level of glycemia in children and adolescents with type 1 diabetes mellitus: data of long term ECG monitoring and registration of motor activity Kardiologiia 52(6): 48-54
Zoppi, M.; Török, M.; Stoller-Güleryüz, D.; Winzenried, P.; Marty, H.; Hess, T.; Stucki, P.; Bickel, M.H.; Stocker, F.; Hoigné, R. 1982: Drug side effects as the probable cause of death. Results of the Berne Comprehensive Hospital Drug Monitoring Program Schweizerische Medizinische Wochenschrift 112(49): 1808-1810
Lagier, G.; Vincens, M.; Castot, A. 1983: Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid Therapie 38(3): 303-318
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Vozeh, S. 1984: Drug level determination for optimization of drug therapy. Practical significance and new trends Schweizerische Rundschau für Medizin Praxis 73(49): 1505-1506
Jaźwińska-Tarnawska, E.; Wiela-Hojeńska, A.; Wolańczyk-Medrala, A.; Patkowski, J.; Nittner-Marszalska, M.; Głowacka, K. 2012: Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center Acta Poloniae Pharmaceutica 69(5): 979-984
Greene, R.J. 1973: Drug administration. 2. Drug information at ward level Nursing Times 69(31): 992-993
Ciorciaro, C.; Hartmann, K.; Kuhn, M. 1998: Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center) Schweizerische Medizinische Wochenschrift 128(7): 254-258
Frewin, D.B.; Shaw, D.R.; Bochner, F. 1982: Therapeutic drug monitoring: a survey of sub- and supra-therapeutic serum drug levels in a large teaching hospital New Zealand Medical Journal 95(719): 774-776
Rusakov, N.V.; Pinigin, M.A.; Sabirova, Z.F.; Yuan, A.E. 2006: Measures for better sociohygienic monitoring at the regional level Gigiena i Sanitariia 1: 8-9